SCHEMBL7987233

SCHEMBL7987233

CCCc1nc2ncn(CCCc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
KDM4E B2RXH2 1/20 0.58
POLB P06746 1/20 0.58
MAPK1 P28482 1/20 0.58
CNOT7 Q9UIV1 1/20 0.49
TSHR P16473 1/20 0.49
HCAR2 Q8TDS4 4/20 0.47
HPGD P15428 1/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
RECQL P46063 1/20 0.43
MDM2 Q00987 1/20 0.43
PDE4A P27815 1/20 0.43
ADORA2A P29274 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985079 0.93 KDM4E (0.49) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7974261 0.92 LMNA (0.60) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7988855 0.89 LMNA (0.56) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7989405 0.87 SMN1; SMN2 (0.57) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7984942 0.87 KDM4E (0.56) LMNAKDM4EPOLBMAPK1CNOT7
Hydrochloric Acid SCHEMBL7988003 0.86 KDM4E (0.55) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7974531 0.85 KDM4E (0.50) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7987608 0.83 SMN1; SMN2 (0.55) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7987237 0.82 CNOT7 (0.57) LMNAKDM4EPOLBMAPK1CNOT7
SCHEMBL7989564 0.82 SMN1; SMN2 (0.54) LMNAKDM4EPOLBMAPK1CNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed